Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06658496 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PDA for Kidneys Study

Study acronym: PDA4K
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 6 more changesShow less
    • Final enrollment: 27 participants (planned 45)
    • Primary completion date changed from estimate of Jan 2027 to Jul 30, 2026
    • Study completion moved earlier from May 2027 to Dec 1, 2026
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 4 of 4 entries
    • Site details revised
  2. Re-verified, no change to tracked fieldsv8
  3. Primary completion date: Jan 2026 to Jan 2027
    • Study completion date: Jun 2026 to May 2027
    v7
  4. Primary completion date: Jun 2025 to Jan 2026
    • Study completion date: Jun 2025 to Jun 2026
    v6
  5. Re-verified, no change to tracked fieldsv5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date changed from estimate of Dec 2024 to Dec 19, 2024v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  3. Primary and study completion dates: May 2025 to Jun 2025
    • Start date: Nov 2024 to Dec 2024
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury. Researchers will do this by looking at ultrasound images of the heart, analyzing substances in the urine, and evaluating oxygen levels in the kidneys.
Trial Details
NCT Number NCT06658496
Lead Sponsor University of Wisconsin, Madison
Collaborators: The Gerber Foundation
Conditions
(from sponsor)		 Patent Ductus Arteriosus, Congenital Heart Disease
Related terms Ductus Arteriosus, Patent, Heart Defects, Congenital
Enrollment 27 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov